Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd (formerly Sun and Shine Worldwide Limited) has informed BSE that its Board of Directors will meet on Friday, 23rd May 2025. The main agenda is to approve and take on record the audited standalone financial results for the quarter and full year ended 31st March 2025. The meeting may also consider any other business items that the Board deems fit. The intimation has been made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. No financial numbers have been disclosed yet — only the schedule of the board meeting is being communicated.
This is a routine regulatory intimation and has no immediate impact on shareholders. Investors should watch for the actual audited Q4/FY25 results announcement after 23rd May 2025, which may influence stock price direction.